Form D · Biotechnology
ProVazo LLC
Charlottesville, VA · CIK 0001595279
Offering snapshot reported Apr 28, 2015 · SEC filing
- Reported sold
- $90K Offering amount: $150K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 13, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2015 | Initial | $90,000 | No comparison | 5 | SEC filing |
| Dec 27, 2013 | Initial | $90,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-238731
Source: Form D, filed Apr 28, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Andreae | Director |
| Timothy Higgins | Director, Executive |
| Peter Neems | Director, Executive |
| Jessica Ungerleider | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1000 City Walk Way, #101
Charlottesville, VA, 22902
Charlottesville, VA, 22902